Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of AzaSite vs Vigamox in Cataract Surgery
NCT00575380Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2007
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of AzaSite in bacterial eye infection, sponsored by Merck & Co.. Started Dec 2007; status: completed.
02
Drugs
AzaSite
03
Conditions
bacterial eye infection
Beyond the preview
Go deeper on NCT00575380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00575380.